DAFNA Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-48,145
| Closed | -$15.2M | – | 84 |
|
|
2023
Q4 | $15.2M | Sell |
48,145
-4,728
| -9% | -$919K | 3.65% | 7 |
|
|
2023
Q3 | $8.94M | Buy |
52,873
+10,700
| +25% | +$2.01M | 2.78% | 11 |
|
|
2023
Q2 | $9.15M | Sell |
42,173
-36,400
| -46% | -$7.8M | 2.5% | 14 |
|
|
2023
Q1 | $14.3M | Buy |
78,573
+6,546
| +9% | +$1.25M | 4.28% | 5 |
|
|
2022
Q4 | $14.2M | Buy |
72,027
+43,141
| +149% | +$9.25M | 3.99% | 4 |
|
|
2022
Q3 | $6.5M | Sell |
28,886
-33,167
| -53% | -$6.71M | 1.75% | 19 |
|
|
2022
Q2 | $7.85M | Sell |
62,053
-20,000
| -24% | -$2.3M | 2.14% | 12 |
|
|
2022
Q1 | $10.4M | Buy |
82,053
+9,630
| +13% | +$1.08M | 2.71% | 8 |
|
|
2021
Q4 | $9.49M | Sell |
72,423
-2,162
| -3% | -$279K | 2.39% | 9 |
|
|
2021
Q3 | $9.12M | Buy |
74,585
+21,585
| +41% | +$2.49M | 2.42% | 10 |
|
|
2021
Q2 | $6.04M | Buy |
53,000
+5,000
| +10% | +$584K | 1.26% | 23 |
|
|
2021
Q1 | $5.77M | Buy |
48,000
+31,332
| +188% | +$3.55M | 1.37% | 19 |
|
|
2020
Q4 | $1.69M | Buy |
16,668
+7,437
| +81% | +$689K | 0.5% | 45 |
|
|
2020
Q3 | $714K | Hold |
9,231
| – | – | 0.23% | 66 |
|
|
2020
Q2 | $1.03M | Buy |
9,231
+3,000
| +48% | +$261K | 0.3% | 56 |
|
|
2020
Q1 | $449K | Buy |
+6,231
| New | +$533K | 0.19% | 67 |
|
|
2019
Q4 | – | Sell |
-11,192
| Closed | -$183K | – | 91 |
|
|
2019
Q3 | $183K | Buy |
11,192
+1,192
| +12% | +$23.2K | 0.07% | 84 |
|
|
2019
Q2 | $200K | Buy |
+10,000
| New | +$200K | 0.08% | 81 |
|